68Ga-DOTATATE PET/CT in Pituitary Carcinoma.

Authors :: Kaya G
Soydas Turan B
Dagdelen S
Berker M
Tuncel M
Source :: Clinical nuclear medicine [Clin Nucl Med] 2021 Dec 01; Vol. 46 (12), pp. 996-998.
Publication Year :: 2021
Abstract: Abstract: A 47-year-old woman with atypical pituitary adenoma was referred to the neurosurgery department due to recent back pain. She had multiple transsphenoidal surgery, stereotactic body radiation, and 177Lu-DOTATATE therapy. Her spinal MRI showed multiple spinal masses. The patient underwent 68Ga-DOTATATE PET/CT to confirm the metastatic spread of the disease. PET/CT images showed increased uptake at the local recurrent tumor site and spinal metastases confirmed by biopsy to pituitary carcinoma. Our case presents the role of 68Ga-DOTATATE PET/CT in patients with pituitary carcinoma.<br />Competing Interests: Conflicts of interest and sources of funding: none declared.<br /> (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)